← Back to catalogue
FLEX Mono Mo A-Hu Renal Cell Carcinoma Marker Cl SPM314 RTU (Link)
FDA UDIClass I (US FDA UDI)
Identity
- Trade Name
- FLEX Mono Mo A-Hu Renal Cell Carcinoma Marker Cl SPM314 RTU (Link) FDA UDI
- Generic Name
- Renal cell carcinoma antigen IVD, antibody FDA UDI
- Device Name
- FLEX Monoclonal Mouse Anti-Human Renal Cell Carcinoma Marker Clone SPM314 Ready-to-Use (Link) FDA UDI
- Model / Reference
- IR075 FDA UDI
- Description
- FLEX Monoclonal Mouse Anti-Human Renal Cell Carcinoma Marker Clone SPM314 Ready-to-Use (Link) FDA UDI
Identifiers
- Primary DI / UDI-DI
- 05700571101247 FDA UDI
- FDA Product Code
- NJT FDA UDI
- GMDN Term
- Renal cell carcinoma antigen IVD, antibody FDA UDI
Classification
- Device Class
- Class I FDA UDI
- Regulation Number
- 864.1860 FDA UDI
- Commercial Distribution
- Not in Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
Yes
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
FLEX Mono Mo A-Hu Renal Cell Carcinoma Marker Cl SPM314 RTU (Link) by Agilent Technologies Inc. — Class I — FDA UDI — listed in FDA GUDID
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class I | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Agilent Technologies Inc.
Sources (1)
- FDA UDI 99bbda86-8ddc-4f7b-8d08-573bb31eb8ae 37 fields · synced Jun 8, 2026